Literature DB >> 8909650

The 25-year health care costs of women who remain overweight after 40 years of age.

R D Gorsky1, E Pamuk, D F Williamson, P A Shaffer, J P Koplan.   

Abstract

BACKGROUND AND
PURPOSE: Previously published reports strongly suggest that being overweight is a risk factor for coronary heart disease, hypertension, diabetes, gallstones, and osteoarthritis in women. Substantial health care and medication costs are associated with these chronic health conditions. We used an incidence-based analysis to estimate the excess costs associated with women maintaining an overweight status during the 25-year period from age 40 to 65 years.
METHODS: The health care costs of three hypothetical cohorts of 10,000 40-year-old women were extrapolated to age 65. The non-overweight cohort maintained a body mass index (BMI; weight [kg]/height [m2]) of 21 to 24.9; the moderately overweight cohort maintained a BMI of 25 to 28.9; the severely overweight cohort maintained a BMI of > or = 29. The number of fatal and nonfatal health outcomes in each cohort for heart disease, hypertension, diabetes mellitus, gallstones, and osteoarthritis was calculated with their associated costs.
RESULTS: We estimated that when compared with the non-overweight cohort of 10,000 women, the cohort of 10,000 women who had a BMI of > or = 29 incurred excess costs of $53 million over a 25 year period (discounted at 3% per year) and 497 excess deaths. The cohort of 10,000 women who had a BMI of 25-28.9 incurred excess costs of $22 million (discounted at 3% per year) and 212 excess deaths, compared with the non-overweight cohort.
CONCLUSIONS: The results of this study indicate that an estimated $16 billion will be spent during the next 25 years treating health outcomes associated with overweight in middle-aged women in the United States. Thus, a substantial health burden is associated with the increasing prevalence of overweight women in the United States. Preventing excess coronary heart disease, gall-stones, osteoarthritis, hypertension, and diabetes through prevention of weight gain, particularly among reproductive-aged women, may be a cost-effective strategy.

Entities:  

Mesh:

Year:  1996        PMID: 8909650

Source DB:  PubMed          Journal:  Am J Prev Med        ISSN: 0749-3797            Impact factor:   5.043


  7 in total

Review 1.  Outcomes of pharmacological and surgical treatment for obesity.

Authors:  J Cerulli; M Malone
Journal:  Pharmacoeconomics       Date:  1998-09       Impact factor: 4.981

Review 2.  Direct medical cost of overweight and obesity in the USA: a quantitative systematic review.

Authors:  A G Tsai; D F Williamson; H A Glick
Journal:  Obes Rev       Date:  2011-01       Impact factor: 9.213

3.  The economic impact of obesity in the United States.

Authors:  Ross A Hammond; Ruth Levine
Journal:  Diabetes Metab Syndr Obes       Date:  2010-08-30       Impact factor: 3.168

4.  Psychosocial correlates of overweight or obese status in Latino adults with coronary artery disease.

Authors:  C Boutin-Foster; A Rodriguez
Journal:  J Immigr Minor Health       Date:  2008-07-09

5.  An assessment of obesity among African-American women in an inner city primary care clinic.

Authors:  Terry A Jacobson; Felicia Morton; Kara L Jacobson; Sameer Sharma; Dinamarie C Garcia
Journal:  J Natl Med Assoc       Date:  2002-12       Impact factor: 1.798

6.  Obesity and insulin resistance are associated with reduced activity in core memory regions of the brain.

Authors:  Lucy G Cheke; Heidi M Bonnici; Nicola S Clayton; Jon S Simons
Journal:  Neuropsychologia       Date:  2017-01-16       Impact factor: 3.139

7.  The cost-effectiveness of a school-based overweight program.

Authors:  Henry Shelton Brown; Adriana Pérez; Yen-Peng Li; Deanna M Hoelscher; Steven H Kelder; Roberto Rivera
Journal:  Int J Behav Nutr Phys Act       Date:  2007-10-01       Impact factor: 6.457

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.